Video

New Rule-Out Test for Lung Cancer Increases Diagnostic Precision

Gerard A. Silvestri, M.D., a lung cancer pulmonologist at MUSC, led a study that shows that a new biomarker is 98 percent effective at distinguishing benign from malignant lung nodules.

Video

Reanimating the Paralyzed Face

Samuel L. Oyer, M.D., discusses a technique used in facial reanimation surgery — masseter-to-facial nerve transfer — that can restore a patient’s ability to smile.

Video

Pancreatic Head Resection for Localized Pancreatic Cancer

MUSC Health gastrointestinal surgeon Katherine A. Morgan, M.D., discusses the Whipple procedure as a surgical treatment for localized pancreatic cancer.

Video

Instagrams of the Immune System - Predict Responses to Immunotherapy

Carsten Krieg, Ph.D.,discusses how “Instagrams of the immune system,” captured by a new technology, made it possible to identify biomarkers of response to immunotherapy in patients with melanoma.

Video

Advanced Glycation End Products: A Lifestyle Biomarker

Study of advanced glycation end produces (AGEs) through dietary and exercise intervention to see if improvement of quality of life decreases tumor recurrence in patients.

Video

Protecting Heart Health Before, During and After Cancer Treatment

Thanks to improved treatments, patients with cancer are living longer. Some of those treatments, however, are associated with cardiotoxicities that can put patients at risk for heart problems.

Video

Transanal Minimally Invasive Surgery

Transanal minimally invasive surgery (TAMIS) is a new, minimally invasive approach to rectal surgery that is performed through one of the body’s natural orifices — the anus.

Video

Catalyzing the Translation of New Cancer Therapies into the Clinic

Raymond N. DuBois MD, dean of the College of Medicine at the Medical University of South Carolina discusses Stand Up to Cancer’s Catalyst Program.

Video

Video-Assisted Thoracoscopic Surgery

MUSC Health thoracic surgeon Chadrick E. Denlinger, M.D. discusses video-assisted thoracoscopic surgery for the treatment of stage 1 nonsmall cell lung cancer (NSCLC).

Document

Precision Medicine: Exome Sequencing Helps Physicians Target Genomic Variations within Tumors

As part of MUSC's growing transnational genomics program, a genomics tumor board has been created to bring diverse specialists together to help physicians diagnose and manage cancer.

Document

Up From Below: New Minimally Invasive Surgery for Patients with Tumors in the Lower Rectum

Transanal total mesorectal excision (TaTME) has garnered a great surgery because it represents a reversal of perspective—literally— about how best to excise tumors and the surrounding mesorectal envelope in the lower third of the rectum.

Document

A Class ACT: MUSC Immunologists are Optimizng Adoptive Cell Transfer for Antitumor Treatments

Researchers are using adoptive cell transfer (ACT) to reinforce the ranks of a patient’s own T cells—the body’s warriors—and train them to better target the patient’s cancer.

Document

Taking Center Stage: Immunotherapy Joins the Ranks of Mainstream Cancer Treatments

News that novel T cell–based immunotherapeutic approaches such as immune checkpoint blockade and adoptive cell transfer are achieving durable responses in patients with aggressive cancers has created excitement in the world of cancer research.

Document

Right on Target: Clinical Genomics Identifies Cancer Patients Likely to Benefit from Targeted Therapies

Genomics screening can improve the odds for some cancer patients, potentially identifying mutations associated with cancer subtypes for which targeted therapies exist or are in development.